|
Originally published In Press as doi:10.1074/jbc.M307625200 on September 2, 2003
J. Biol. Chem., Vol. 278, Issue 45, 44424-44428, November 7, 2003
Discovery of a Small Molecule That Inhibits Cell Division by Blocking FtsZ, a Novel Therapeutic Target of Antibiotics*
Jun Wang ,
Andrew Galgoci,
Srinivas Kodali,
Kithsiri B. Herath,
Hiranthi Jayasuriya,
Karen Dorso,
Francisca Vicente,
Antonio González,
Doris Cully,
David Bramhill, and
Sheo Singh
From the
Department of Human and Animal Infectious Disease and Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065
The emergence of bacterial resistance to antibiotics is a major health problem and, therefore, it is critical to develop new antibiotics with novel modes of action. FtsZ, a tubulin-like GTPase, plays an essential role in bacterial cell division, and its homologs are present in almost all eubacteria and archaea. During cell division, FtsZ forms polymers in the presence of GTP that recruit other division proteins to make the cell division apparatus. Therefore, inhibition of FtsZ polymerization will prevent cells from dividing, leading to cell death. Using a fluorescent FtsZ polymerization assay, the screening of >100,000 extracts of microbial fermentation broths and plants followed by fractionation led to the identification of viriditoxin, which blocked FtsZ polymerization with an IC50 of 8.2 µg/ml and concomitant GTPase inhibition with an IC50 of 7.0 µg/ml. That the mode of antibacterial action of viriditoxin is via inhibition of FtsZ was confirmed by the observation of its effects on cell morphology, macromolecular synthesis, DNA-damage response, and increased minimum inhibitory concentration as a result of an increase in the expression of the FtsZ protein. Viriditoxin exhibited broad-spectrum antibacterial activity against clinically relevant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci, without affecting the viability of eukaryotic cells.
Received for publication, July 15, 2003
, and in revised form, August 29, 2003.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Merck & Co., Inc., P. O. Box 2000, R80Y-205, Rahway, NJ 07065. Tel.: 732-594-2776; Fax: 732-594-1399; E-mail: jun_wang2{at}merck.com.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Sudhamsu, G. I. Lee, D. F. Klessig, and B. R. Crane
The Structure of YqeH: AN AtNOS1/AtNOA1 ORTHOLOG THAT COUPLES GTP HYDROLYSIS TO MOLECULAR RECOGNITION
J. Biol. Chem.,
November 21, 2008;
283(47):
32968 - 32976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Haydon, N. R. Stokes, R. Ure, G. Galbraith, J. M. Bennett, D. R. Brown, P. J. Baker, V. V. Barynin, D. W. Rice, S. E. Sedelnikova, et al.
An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
Science,
September 19, 2008;
321(5896):
1673 - 1675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Huecas, C. Schaffner-Barbero, W. Garcia, H. Yebenes, J. M. Palacios, J. F. Diaz, M. Menendez, and J. M. Andreu
The Interactions of Cell Division Protein FtsZ with Guanine Nucleotides
J. Biol. Chem.,
December 28, 2007;
282(52):
37515 - 37528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, D. E. Anderson, M. Rajagopalan, and H. P. Erickson
Assembly Dynamics of Mycobacterium tuberculosis FtsZ
J. Biol. Chem.,
September 21, 2007;
282(38):
27736 - 27743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, S. Kodali, S. H. Lee, A. Galgoci, R. Painter, K. Dorso, F. Racine, M. Motyl, L. Hernandez, E. Tinney, et al.
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
PNAS,
May 1, 2007;
104(18):
7612 - 7616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Young, H. Jayasuriya, J. G. Ondeyka, K. Herath, C. Zhang, S. Kodali, A. Galgoci, R. Painter, V. Brown-Driver, R. Yamamoto, et al.
Discovery of FabH/FabF Inhibitors from Natural Products
Antimicrob. Agents Chemother.,
February 1, 2006;
50(2):
519 - 526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Stokes, J. Sievers, S. Barker, J. M. Bennett, D. R. Brown, I. Collins, V. M. Errington, D. Foulger, M. Hall, R. Halsey, et al.
Novel Inhibitors of Bacterial Cytokinesis Identified by a Cell-based Antibiotic Screening Assay
J. Biol. Chem.,
December 2, 2005;
280(48):
39709 - 39715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Paradis-Bleau, F. Sanschagrin, and R. C. Levesque
Peptide inhibitors of the essential cell division protein FtsA
Protein Eng. Des. Sel.,
February 1, 2005;
18(2):
85 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kodali, A. Galgoci, K. Young, R. Painter, L. L. Silver, K. B. Herath, S. B. Singh, D. Cully, J. F. Barrett, D. Schmatz, et al.
Determination of Selectivity and Efficacy of Fatty Acid Synthesis Inhibitors
J. Biol. Chem.,
January 14, 2005;
280(2):
1669 - 1677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Margalit, L. Romberg, R. B. Mets, A. M. Hebert, T. J. Mitchison, M. W. Kirschner, and D. RayChaudhuri
Targeting cell division: Small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality
PNAS,
August 10, 2004;
101(32):
11821 - 11826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Paradis-Bleau, F. Sanschagrin, and R. C. Levesque
Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for development of novel antimicrobials
J. Antimicrob. Chemother.,
July 1, 2004;
54(1):
278 - 280.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|